ACTIVE

OLFADOG BIOTECH

Financial year 2024 · Closed on 31/12/2024

Net result-188,7 k €+53,3 %over 1 year
Gross margin-8,2 k €+79,3 %over 1 year
Equity1,4 M €+70,8 %over 1 year

Identity

Source · BCE/KBO

OLFADOG BIOTECH is a Public limited company incorporated in 2022. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Waterloo.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0794.892.333
Incorporation
16/12/2022
Legal form
Public limited company
Registered office
Drève Richelle 161P box 4
1410 Waterloo · WallonieSee on map
Contributed capital
2 035 640,09 €
Latest accounts
31/12/2024
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 2 filings

Trend over 2 financial years

20242023
Income statement
Gross margin-8,2 k €-39,5 k €
EBITDA-8,6 k €-39,9 k €
Operating result-188,6 k €-404,4 k €
Net result-188,7 k €-404,4 k €
Balance sheet
Equity1,4 M €844,6 k €
Total assets1,8 M €1,5 M €
Cash633,5 k €217,5 k €
Debts360,3 k €670,5 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

4 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
GBIO CONSULTING & MANAGEMENT0777.440.449Represented by Roland GORDON-BERESFORD
Director16/12/2022 → 31/05/2028
Hexagon Advisory0724.846.752Represented by Jean-François POLLET
Director16/12/2022 → 31/05/2028
Luc LIEGEOIS
Director16/12/2022 → 31/05/2028
T-I0426.561.458Represented by Stefaan VANDAELE
Director16/12/2022 → 31/05/2028

Other companies at this address

Drève Richelle 161P 1410 Waterloo
CompanyCBE no.
ACFTPERFO● Active
0754.648.716
CREATIVE WORK● Active
0478.616.806
EOLE Services● Active
0745.589.213
Floridienne● Active
0403.064.593
GEOPRESS● Active
0450.191.747
Pharmazym● Active
1007.156.740
SHARE METALS● Active
1044.352.082
SNAM Belgium● Active
1042.466.027
0402.798.933

Full financial information

Source · NBB
20242023
Type of accountAbridged modelAbridged model
Start of the financial year01/01/202416/12/2022
Closing of the financial year31/12/202431/12/2023
Length of the financial year12 months13 months
Filing date09/07/202514/06/2024
General meeting30/06/202529/05/2024
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 2 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202430/06/202509/07/2025FrenchPDF
Abridged model31/12/202329/05/202414/06/2024FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

4 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
GBIO CONSULTING & MANAGEMENT0777.440.449Represented by Roland GORDON-BERESFORD
Director16/12/2022 → 31/05/2028
Hexagon Advisory0724.846.752Represented by Jean-François POLLET
Director16/12/2022 → 31/05/2028
Luc LIEGEOIS
Director16/12/2022 → 31/05/2028
T-I0426.561.458Represented by Stefaan VANDAELE
Director16/12/2022 → 31/05/2028

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares06/01/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Other20/12/2022
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings2 filings
Mandates
T-I
Hexagon Advisory
GBIO CONSULTING & MANAGEMENT
Luc LIEGEOIS
2022202320242025202620272028
OLFADOG BIOTECH
Drève Richelle 161P bte 4, 1410 Waterloo
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Drève Richelle 161P bte 4, 1410 WaterlooCurrent
accounts 2023 → 2024
Accounts 2024 · 2025-00255720

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
OLFADOG BIOTECHCurrent
accounts 2023 → 2024
Accounts 2024 · 2025-00255720

Events

  1. 2024
    Annual accounts 2024-188,7 k €↑
  2. 2023
    Annual accounts 2023-404,4 k €
  3. 16/12/2022
    IncorporationPublic limited company